| mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.21 |
0.0004 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
| mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.003 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |